Pharmaceuticals, Biotechnology and Life Sciences
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the U.S.…
SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — In a release issued on Tuesday, September 28th by Sorrento Therapeutics, Inc. (NASDAQ: SRNE), please…
PRESS RELEASE AB SCIENCE RECEIVES REGULATORY AUTHORIZATION TO COMMENCE A SECOND PHASE 2 COVID STUDY STUDY DESIGN FOCUSES DIRECTLY ON…
BUFFALO, N.Y., Sept. 27, 2021 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual…
— Additional ~$19M Funding for Expanded Anthrax PEP Development Program — BARDA Contract Now Valued at Up to ~$304M —…
GAITHERSBURG, Md., Sept. 27, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to…
GAITHERSBURG, Md., Sept. 27, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it…
Boca Raton, FL, Sept. 27, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company…
With the launch of “Unlocking Growth – Powered by Biotech” Novozymes presents its 2025-strategy. It sets out an organic sales…
Please read the full announcement in PDF Attachment 2021_46_Novozymes_announces_ 2025_strategy